Article info
PDFNeurological rarities
Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome
- Correspondence to Dr M M Wickremaratchi, Neurology Department, Western Sussex Hospital NHS Trust (Worthing Hospital), Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK; mirdhu2001{at}yahoo.com
Citation
Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome
Publication history
- First published April 5, 2013.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Antiglycine-receptor encephalomyelitis with rigidity
- Progressive encephalomyelitis with rigidity and myoclonus (PERM)
- Stiff-person syndrome: insights into a complex autoimmune disorder
- Stiff-person syndrome
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Antiglycine receptor antibody and encephalomyelitis with rigidity and myoclonus (PERM) related to small cell lung cancer
- Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases
- Stiff person syndrome
- Republished review: Autoantibody testing in encephalopathies
- Autoantibody testing in encephalopathies